In contrast, dysregulation of ERCC3 (Excision repair cross-complementation group 3) levels has not been previously associated to EC, although different studies highlight the suppressor role of ERCC3 silencing in different cancers, as pancreatic or liver carcinomas [83, 84]. Here, ERCC3 is linked to hepatocellular carcinoma.